Search
Search Results
-
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia
BackgroundHistorically, adults with relapsed-refractory acute lymphoblastic leukemia (ALL) experienced poor outcomes with intensive chemotherapy....
-
Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?
Purpose of ReviewTo evaluate recent clinical trials focusing on patients with hypertriglyceridemia.
Recent FindingsRandomized clinical trials have...
-
Importance of Nutrition Security to CVD Prevention Efforts in the USA
Purpose of ReviewThe importance of addressing nutrition security for the primary and secondary prevention of cardiovascular disease (CVD) in the USA...
-
Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study
IntroductionThe CAPTURE study estimated the global prevalence of established cardiovascular disease (CVD) and characterized the usage of...
-
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
Purpose of ReviewChronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review...
-
Advances, Challenges, and Progress in Cardiac Rehabilitation in Chronic CVD Management
Purpose of ReviewTo review the benefits, challenges, and advances in cardiac rehabilitation (CR) in the management of cardiovascular disease (CVD).
...
-
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis
BackgroundAnti-vascular endothelial growth factor (anti-VEGF) therapy is commonly used intravitreally for diabetic proliferative retinopathy, but...
-
Approaches to Prevent and Manage Cardiovascular Disease in Patients Receiving Therapy for Prostate Cancer
Purpose of ReviewProstate cancer (PCa) is amongst the most common cancers in men worldwide. Cardiovascular (CV) risk factors and CV disease (CVD) are...
-
Trajectories of CVD medication after statutory retirement: contributions of pre-retirement sociodemographic, work and health-related factors: a register study in Finland
BackgroundCardiovascular diseases (CVDs) are prevalent in older people, but few studies focus on developmental patterns in CVD medication directly...
-
“Patients would probably be more compliant to therapy if encouraged by those around them”: a qualitative study exploring primary care physicians’ perceptions on barriers to CVD risk management
BackgroundPublic health prevention strategies have been developed to overcome the disease burden. Despite all the available resources, there have...
-
Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer
Purpose of ReviewCardiovascular disease (CVD) is the leading cause of non-cancer mortality in men with prostate cancer. This review summarizes the...
-
Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review
Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide, consuming huge healthcare budget. For CVD patients, the prompt...
-
Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review
Menopause is accompanied by several metabolic adaptations, which are related to insulin resistance, increased total body fat mass, and central...
-
Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia
Introduction/objectivesTo investigate the role of urate-lowering therapy (ULT) in the prevention of cardiovascular disease (CVD) in patients with...
-
Effect of overall lifestyle on the all-cause mortality and cardiovascular disease death in dyslipidemia patients with or without lipid-lowering therapy: a cohort study
BackgroundLifestyle adjustment has been reported as one of the interventions for dyslipidemia. This study aimed to explore the effect of overall...
-
Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation
BackgroundChronic kidney disease (CKD) patients sustain a fairly high prevalence of cardiovascular disease (CVD). Microvascular inflammation is an...
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer
PurposeStudies comparing the effect of aromatase inhibitor (AI) and tamoxifen use on cardiovascular disease (CVD) risk factors in hormone...
-
Lymphocytes ≥ 2.9 (109/L) in Newly Diagnosed Diabetes Are A Predictor of Future CVD Events
ObjectiveAtherosclerosis is considered a chronic inflammatory condition. The immune system is a key mediator in the initiation and progression of...
-
Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men
Purpose of ReviewThe purpose of this review is to analyze the link between testosterone replacement therapy (TRT) and adverse cardiovascular (CV)...
-
High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis
The pathological consequences of inflammation persist in people living with the human immunodeficiency virus (PLWH), regardless of the positive...
